World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01032096
Date of registration: 14/12/2009
Primary sponsor: Royal Marsden NHS Foundation Trust
Public title: The Physiological Response to Routine Head and Neck Cancer Surgery
Scientific title: The Neuroendocrine, Metabolic, Inflammatory and Immune Responses to Routine Head and Neck Surgery. An Observational Pilot Study
Date of first enrolment: May 2009
Target sample size: 15
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT01032096
Study type:  Observational
Study design:  Observational Model: Cohort, Time Perspective: Prospective  
Countries of recruitment
United Kingdom
Contacts
Name:   Dr Craig Carr
Address: 
Telephone: 02078118059
Email: craig.carr@rmh.nhs.uk
Affiliation: 
Name:   Dr Craig Carr
Address: 
Telephone:
Email:
Affiliation:  The Royal Marsden NHS Foundation Trust
Key inclusion & exclusion criteria

Inclusion Criteria:

- Elective unilateral neck dissections (Levels I-V) and/or Hemithyroidectomy surgery.

- Royal Marsden Hospital patients with head and neck cancer - all histological
sub-types.

- Capable of providing informed consent

- Age >17

- American Society of Anaesthesiologists Classification I-III.

Exclusion Criteria:

- Past history of ipsilateral neck dissection.

- Bilateral neck dissection

- A recent course of systemic steroids (< 3 months)

- Pregnancy

- Involvement in drug trials

- On following medications: Interleukins, Interferons, Immunosuppressants and long term
opiates

- Recent Synacthen Test (within 48 hours)

- Emergency surgery

- American Society of Anaesthesiologists Classification IV-V.



Age minimum: 18 Years
Age maximum: 80 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Head and Neck Cancer
Intervention(s)
Primary Outcome(s)
The maximum increase (from baseline to day 3 post-op) in cortisol, IL1 and IL6 will be calculated together with their standard deviations. [Time Frame: No]
Secondary Outcome(s)
Description of other blood parameters related to stress response. [Time Frame: No]
Maximum change in IL2, IL3, IL8 and IL10 from baseline to day 3 post-op. [Time Frame: No]
The area under the curve for insulin concentration. [Time Frame: No]
Secondary ID(s)
CCR3168
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history